Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.33 USD | +2.26% | -13.67% | -38.49% |
Financials (USD)
Sales 2024 * | 32.51M | Sales 2025 * | 133M | Capitalization | 801M |
---|---|---|---|---|---|
Net income 2024 * | -390M | Net income 2025 * | -316M | EV / Sales 2024 * | 8.93 x |
Net cash position 2024 * | 511M | Net cash position 2025 * | 356M | EV / Sales 2025 * | 3.36 x |
P/E ratio 2024 * |
-2.09
x | P/E ratio 2025 * |
-2.68
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.44% |
Latest transcript on Sage Therapeutics, Inc.
1 day | +2.26% | ||
1 week | -13.67% | ||
Current month | -28.87% | ||
1 month | -30.86% | ||
3 months | -48.75% | ||
6 months | -26.92% | ||
Current year | -38.49% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 16 M€ | -9.75% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 13.33 | +2.26% | 1,258,725 |
24-04-18 | 13.04 | +3.70% | 1,757,641 |
24-04-17 | 12.57 | -19.58% | 4,315,890 |
24-04-16 | 15.63 | +2.02% | 1,939,459 |
24-04-15 | 15.32 | -0.78% | 846,150 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.49% | 783M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- SAGE Stock